{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:38:16Z","timestamp":1761100696381},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2004,3,29]],"date-time":"2004-03-29T00:00:00Z","timestamp":1080518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,3,29]],"date-time":"2004-03-29T00:00:00Z","timestamp":1080518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2004,5,1]]},"DOI":"10.1038\/sj.bmt.1704477","type":"journal-article","created":{"date-parts":[[2004,3,29]],"date-time":"2004-03-29T09:07:55Z","timestamp":1080551275000},"page":"891-900","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies"],"prefix":"10.1038","volume":"33","author":[{"given":"T","family":"Hamaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Kami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S-W","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Murashige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Sakiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Imataki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Heike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Tanosaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Masuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Miyakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Tobinai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Takaue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,3,29]]},"reference":[{"key":"BF1704477_CR1","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1200\/JCO.1989.7.8.1071","volume":"7","author":"MJ Keating","year":"1989","unstructured":"Keating MJ, Kantarjian H, Smith TL et al. Response to salvage therapy and survival after relapse in acute myelogenous leukemia. J Clin Oncol 1989; 7: 1071\u20131080.","journal-title":"J Clin Oncol"},{"key":"BF1704477_CR2","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1182\/blood.V98.8.2326","volume":"98","author":"T de Witte","year":"2001","unstructured":"de Witte T, Suciu S, Verhoef G et al. Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS. Blood 2001; 98: 2326\u20132331.","journal-title":"Blood"},{"key":"BF1704477_CR3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0145-2126(00)00088-6","volume":"24","author":"U Germing","year":"2000","unstructured":"Germing U, Gattermann N, Strupp C et al. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk Res 2000; 24: 983\u2013992.","journal-title":"Leuk Res"},{"key":"BF1704477_CR4","unstructured":"World Health Organization. Pathology and Genetics. Tumours of Hematopoietic and Lymphoid Tissues. World Health Organization: Geneva, 2001."},{"key":"BF1704477_CR5","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJM199905273402107","volume":"340","author":"ML Heaney","year":"1999","unstructured":"Heaney ML, Golde DW . Myelodysplasia. N Engl J Med 1999; 340: 1649\u20131660.","journal-title":"N Engl J Med"},{"key":"BF1704477_CR6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/281490a0","volume":"281","author":"MM Bortin","year":"1979","unstructured":"Bortin MM, Truitt RL, Rimm AA, Bach FH . Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity. Nature 1979; 281: 490\u2013491.","journal-title":"Nature"},{"key":"BF1704477_CR7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555\u2013562.","journal-title":"Blood"},{"key":"BF1704477_CR8","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood.V89.7.2578","volume":"89","author":"JE Anderson","year":"1997","unstructured":"Anderson JE, Gooley TA, Schoch G et al. Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy. Blood 1997; 89: 2578\u20132585.","journal-title":"Blood"},{"key":"BF1704477_CR9","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1182\/blood.V80.4.1090.1090","volume":"80","author":"JC Biggs","year":"1992","unstructured":"Biggs JC, Horowitz MM, Gale RP et al. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. Blood 1992; 80: 1090\u20131093.","journal-title":"Blood"},{"key":"BF1704477_CR10","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","volume":"89","author":"S Giralt","year":"1997","unstructured":"Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 89: 4531\u20134536.","journal-title":"Blood"},{"key":"BF1704477_CR11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756\u2013763.","journal-title":"Blood"},{"key":"BF1704477_CR12","first-page":"59","volume-title":"Non-myeloablative Stem Cell Transplantation (NST)","author":"S Giralt","year":"2000","unstructured":"Giralt S . Non-myeloablative stem cell transplantation in myeloid leukemias \u2013 The M.D. Anderson Cancer Center experience. In: Giralt S, Slavin S (eds.). Non-myeloablative Stem Cell Transplantation (NST). Darwin Scientific Publishing Limited: Oxfordshire, 2000; pp 59\u201372."},{"key":"BF1704477_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1182\/blood.V97.3.631","volume":"97","author":"S Giralt","year":"2001","unstructured":"Giralt S, Thall PF, Khouri I et al. Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood 2001; 97: 631\u2013637.","journal-title":"Blood"},{"key":"BF1704477_CR14","first-page":"1014","volume":"8","author":"T Saito","year":"2002","unstructured":"Saito T, Kanda Y, Kami M et al. Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced\/refractory acute leukemia\/lymphoma. Clin Cancer Res 2002; 8: 1014\u20131020.","journal-title":"Clin Cancer Res"},{"key":"BF1704477_CR15","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704477_CR16","first-page":"250","volume":"28","author":"KM Sullivan","year":"1991","unstructured":"Sullivan KM, Agura E, Anasetti C et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250\u2013259.","journal-title":"Semin Hematol"},{"key":"BF1704477_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/sj.bmt.1703214","volume":"28","author":"Y Kanda","year":"2001","unstructured":"Kanda Y, Mineishi S, Saito T et al. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 689\u2013692.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704477_CR18","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1056\/NEJM199305063281808","volume":"328","author":"PA Pizzo","year":"1993","unstructured":"Pizzo PA . Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328: 1323\u20131332.","journal-title":"N Engl J Med"},{"key":"BF1704477_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/00007890-200202270-00015","volume":"73","author":"Y Kanda","year":"2002","unstructured":"Kanda Y, Mineishi S, Saito T et al. Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation. Transplantation 2002; 73: 568\u2013572.","journal-title":"Transplantation"},{"key":"BF1704477_CR20","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/sj.bmt.1701779","volume":"23","author":"C Thiede","year":"1999","unstructured":"Thiede C, Florek M, Bornhauser M et al. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant 1999; 23: 1055\u20131060.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704477_CR21","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","volume":"6","author":"S Bearman","year":"1988","unstructured":"Bearman S, Appelbaum FR, Buckner C et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562\u20131568.","journal-title":"J Clin Oncol"},{"key":"BF1704477_CR22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1200\/JCO.1990.8.5.813","volume":"8","author":"BD Cheson","year":"1990","unstructured":"Cheson BD, Cassileth PA, Head DR et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990; 8: 813\u2013819.","journal-title":"J Clin Oncol"},{"key":"BF1704477_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/sj.bmt.1702500","volume":"26","author":"M Bornhauser","year":"2000","unstructured":"Bornhauser M, Thiede C, Schuler U et al. Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin. Bone Marrow Transplant 2000; 26: 119\u2013125.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704477_CR24","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1182\/blood.V94.9.3234","volume":"94","author":"R Childs","year":"1999","unstructured":"Childs R, Clave E, Contentin N et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood 1999; 94: 3234\u20133241.","journal-title":"Blood"},{"key":"BF1704477_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF00694339","volume":"25","author":"LB Grochow","year":"1989","unstructured":"Grochow LB, Jones RJ, Brundrett RB et al. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol 1989; 25: 55\u201361.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5 Suppl. 8","key":"BF1704477_CR26","first-page":"39","volume":"17","author":"M Grever","year":"1990","unstructured":"Grever M, Leiby J, Kraut E et al. A comprehensive phase I and II clinical investigation of fludarabine phosphate. Semin Oncol 1990; 17 (5 Suppl. 8): 39\u201348.","journal-title":"Semin Oncol"},{"key":"BF1704477_CR27","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJM199004193221605","volume":"322","author":"LD Piro","year":"1990","unstructured":"Piro LD, Carrera CJ, Carson DA, Beutler E . Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990; 322: 1117\u20131121.","journal-title":"N Engl J Med"},{"key":"BF1704477_CR28","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1200\/JCO.1994.12.10.2216","volume":"12","author":"BD Cheson","year":"1994","unstructured":"Cheson BD, Vena DA, Foss FM, Sorensen JM . Neurotoxicity of purine analogs: a review. J Clin Oncol 1994; 12: 2216\u20132228.","journal-title":"J Clin Oncol"},{"key":"BF1704477_CR29","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1182\/blood.V80.12.2964.2964","volume":"80","author":"JH Antin","year":"1992","unstructured":"Antin JH, Ferrara JL . Cytokine dysregulation and acute graft-versus-host disease. Blood 1992; 80: 2964\u20132968.","journal-title":"Blood"},{"key":"BF1704477_CR30","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1056\/NEJM198603203141201","volume":"314","author":"R Storb","year":"1986","unstructured":"Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729\u2013735.","journal-title":"N Engl J Med"},{"key":"BF1704477_CR31","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood.V74.6.2252.2252","volume":"74","author":"Y Morishima","year":"1989","unstructured":"Morishima Y, Morishita Y, Tanimoto M et al. Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity. The Nagoya Bone Marrow Transplantation Group. Blood 1989; 74: 2252\u20132256.","journal-title":"Blood"},{"key":"BF1704477_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/sj.bmt.1703097","volume":"28","author":"A Hiraoka","year":"2001","unstructured":"Hiraoka A, Ohashi Y, Okamoto S et al. Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001; 28: 181\u2013185.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704477_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/sj.bmt.1701083","volume":"21","author":"P Martin","year":"1998","unstructured":"Martin P, Nash R, Sanders J et al. Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation. Bone Marrow Transplant 1998; 21: 273\u2013279.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704477_CR34","first-page":"29","volume":"45","author":"D Bunn","year":"1996","unstructured":"Bunn D, Lea CK, Bevan DJ et al. The pharmacokinetics of anti-thymocyte globulin (ATG) following intravenous infusion in man. Clin Nephrol 1996; 45: 29\u201332.","journal-title":"Clin Nephrol"},{"key":"BF1704477_CR35","first-page":"553a","volume":"96","author":"R Chopra","year":"2000","unstructured":"Chopra R, Chakraverty R, Chakrabartu S et al. Non-myeloablative conditioning limits transplant related mortality in patients who have previously failed high dose treatment. Blood 2000; 96: 553a.","journal-title":"Blood"},{"key":"BF1704477_CR36","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","volume":"97","author":"PA McSweeney","year":"2001","unstructured":"McSweeney PA, Niederwieser D, Shizuru JA et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390\u20133400.","journal-title":"Blood"},{"key":"BF1704477_CR37","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1182\/blood.V98.13.3595","volume":"98","author":"IF Khouri","year":"2001","unstructured":"Khouri IF, Saliba RM, Giralt SA et al. Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality. Blood 2001; 98: 3595\u20133599.","journal-title":"Blood"},{"key":"BF1704477_CR38","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1182\/blood.V89.9.3323","volume":"89","author":"CP Leith","year":"1997","unstructured":"Leith CP, Kopecky KJ, Godwin J et al. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood 1997; 89: 3323\u20133329.","journal-title":"Blood"},{"issue":"Suppl. 1","key":"BF1704477_CR39","first-page":"16","volume":"76","author":"T Hamaki","year":"2002","unstructured":"Hamaki T, Kami M, Tanimoto T et al. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning (RIST) for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Int J Hematol 2002; 76 (Suppl. 1): 16.","journal-title":"Int J Hematol"},{"key":"BF1704477_CR40","first-page":"680","volume":"42","author":"K Fujimaki","year":"2001","unstructured":"Fujimaki K, Fujisawa S, Aotsuka N et al. Feasibility of early tapering and discontinuation of cyclosporine to intensify the graft-versus-leukemia effect in patients with advanced hematologic neoplasms. Rinsho Ketsueki 2001; 42: 680\u2013684.","journal-title":"Rinsho Ketsueki"},{"key":"BF1704477_CR41","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","volume":"341","author":"B Lowenberg","year":"1999","unstructured":"Lowenberg B, Downing JR, Burnett A . Acute myeloid leukemia. N Engl J Med 1999; 341: 1051\u20131062.","journal-title":"N Engl J Med"},{"key":"BF1704477_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2174\/1568009023334088","volume":"2","author":"Y Oka","year":"2002","unstructured":"Oka Y, Tsuboi A, Elisseeva OA et al. WT1 as a novel target antigen for cancer immunotherapy. Curr Cancer Drug Targets 2002; 2: 45\u201354.","journal-title":"Curr Cancer Drug Targets"},{"key":"BF1704477_CR43","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/89907","volume":"7","author":"P Fontaine","year":"2001","unstructured":"Fontaine P, Roy-Proulx G, Knafo L et al. Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease. Nat Med 2001; 7: 789\u2013794.","journal-title":"Nat Med"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704477","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704477.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704477.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:08:37Z","timestamp":1648076917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,29]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,5,1]]}},"alternative-id":["BF1704477"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704477","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,29]]},"assertion":[{"value":"29 April 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}